Table 2.

Mean ±s.d. oxygen uptake kinetics during moderate-intensity step exercise in the control and RhEPO treatment groups

	Control-Pre	Control-Post	RhEPO-Pre	RhEPO-Post
Baseline V˙O2 (l min−1)	0.83 ± 0.04	0.79 ± 0.07	0.71 ± 0.12	0.74 ± 0.11
Primary time delay (s)	13 ± 3	16 ± 3	13 ± 6	14 ± 4
Phase II time constant (s)	27 ± 9	27 ± 9	28 ± 8	28 ± 7
Primary amplitude (l min−1)	1.23 ± 0.44	1.24 ± 0.43	0.89 ± 0.32	0.88 ± 0.34
Primary ‘gain’ (ml min−1 W−1)	9.9 ± 0.3	10.0 ± 0.5	10.3 ± 1.7	10.0 ± 1.3